3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Nasopharyngeal Carcinoma
19
Triple Negative Breast Neoplasms
11
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Colorectal Neoplasms
5
Advanced Solid Tumor
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Transitional Cell
4
Carcinoma, Renal Cell
4
Solid Tumor
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Nasopharyngeal Neoplasms
3
Turcot syndrome
2
Sarcoma
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Microsatellite Stable Metastatic Colorectal Cancer
2
Locally Advanced Rectal Cancer
2
Liposarcoma
2
Laryngeal Neoplasms
2
Gestational Trophoblastic Disease
2
Esophageal Neoplasms
2
Interventions
Fulvestrant
4
trastuzumab deruxtecan
2
elacestrant
2
Vinorelbine
2
AZD9833
2
toripalimab
1
talazoparib
1
ribociclib
1
pyrotinib
1
palbociclib
1
olaparib
1
exemestane
1
eribulin
1
disitamab vedotin
1
dalpiciclib
1
apatinib
1
abemaciclib
1
Selective Estrogen Receptor Modulators
1
Radiotherapy
1
RAD1901
1
Letrozole
1
Injections
1
Gonadotropin-Releasing Hormone
1
Everolimus
1
Capecitabine
1
Aromatase Inhibitors
1
Anastrozole
1
AZD5305
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Advanced Breast Cancer
×
toripalimab
×
Clear all
NCT07540533
2026-04-20
2025-370
Henan Cancer Hospital
Phase 2
Recruiting
92 enrolled